NeoGenomics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. 

CEO
Anthony P. Zook
CEOAnthony P. Zook
Employees
2,500
Employees2,500
Headquarters
Fort Myers, Florida
HeadquartersFort Myers, Florida
Founded
1998
Founded1998
Employees
2,500
Employees2,500

NEO Key Statistics

Market cap
1.38B
Market cap1.38B
Price-Earnings ratio
-13.18
Price-Earnings ratio-13.18
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$10.64
High today$10.64
Low today
$10.12
Low today$10.12
Open price
$10.12
Open price$10.12
Volume
512.12K
Volume512.12K
52 Week high
$13.74
52 Week high$13.74
52 Week low
$4.72
52 Week low$4.72

Stock Snapshot

With a market cap of 1.38B, NeoGenomics(NEO) trades at $10.63. The stock has a price-to-earnings ratio of -13.18.

On 2026-05-29, NeoGenomics(NEO) stock traded between a low of $10.12 and a high of $10.64. Shares are currently priced at $10.63, which is +5.0% above the low and -0.1% below the high.

The NeoGenomics(NEO)'s current trading volume is 512.12K, compared to an average daily volume of 1.16M.

During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $13.74 at its peak.

During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $13.74 at its peak.

NEO News

Simply Wall St 2d
Assessing NeoGenomics Valuation After Recent Share Price Momentum Shift - simplywall.st

...

Assessing NeoGenomics Valuation After Recent Share Price Momentum Shift - simplywall.st
TipRanks 7d
NeoGenomics Shareholders Approve Expanded Equity Incentive Plan

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.